Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antitumor activities of IL-12 and mechanisms of action.

× No keyword cloud information.

9 in total

Review 1. The promise of gene therapy in gastrointestinal and liver diseases.

Authors: J Prieto; M Herraiz; B Sangro; C Qian; G Mazzolini; I Melero; J Ruiz
Journal: Gut Date: 2003-05 Impact factor: 23.059

Review 2. Gene therapy: regulations, ethics and its practicalities in liver disease.

Authors: Xi Jin; Yi-Da Yang; You-Ming Li
Journal: World J Gastroenterol Date: 2008-04-21 Impact factor: 5.742

3. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.

Authors: J M Péron; C Bureau; P Gourdy; H Lulka; A Souque; B Calippe; J Selves; T Al Saati; J Bernad; P Cordelier; B Couderc; L Pradayrol; B Pipy; L Buscail; J P Vinel
Journal: Gut Date: 2006-08-04 Impact factor: 23.059

4. IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer.

Authors: J Riemensberger; A Böhle; S Brandau
Journal: Clin Exp Immunol Date: 2002-01 Impact factor: 4.330

5. Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.

Authors: Shu Zheng; Zuo-Xiang Xiao; Yue-Long Pan; Ming-Yong Han; Qi Dong
Journal: World J Gastroenterol Date: 2003-05 Impact factor: 5.742

6. Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-γ-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain.

Authors: Emilia A Gaviglio; Javier M Peralta Ramos; Daniela S Arroyo; Claudio Bussi; Pablo Iribarren; Maria C Rodriguez-Galan
Journal: Int Immunopharmacol Date: 2022-01-21 Impact factor: 4.932

7. Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.

Authors: Maria Cecilia Rodriguez-Galan; Della Reynolds; Silvia G Correa; Pablo Iribarren; Morihiro Watanabe; Howard A Young
Journal: J Immunol Date: 2009-06-17 Impact factor: 5.422

8. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.

Authors: Christian Sänger; Andreas Busche; Gabriele Bentien; Ralf Spallek; Fatima Jonas; Andreas Böhle; Mahavir Singh; Sven Brandau
Journal: BMC Cancer Date: 2004-11-26 Impact factor: 4.430

9. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.

Authors: Kyung-Sun Hwang; Won-Kyung Cho; Jinsang Yoo; Hwan-Jung Yun; Samyong Kim; Dong-Soo Im
Journal: BMC Cancer Date: 2005-05-24 Impact factor: 4.430

9 in total